Novartis Ag (NVS) Profit After Tax (2009 - 2026)
Novartis Ag's (NVS) quarterly Profit After Tax came in at $3.3 billion in Q2 2026, down 19.06% year-over-year from $4.0 billion in Q2 2025, and up 3.2% quarter-over-quarter from $3.2 billion in Q1 2026.
Analysis
Novartis Ag (NVS) Profit After Tax (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Profit After Tax across 18 years of filings, most recently posting $3.3 billion for Q2 2026.
- In Q2 2026, Profit After Tax fell 19.06% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $18.0 billion (down 9.84% YoY), while the FY2025 annual figure was $14.0 billion, up 16.99% from the prior year.
- Profit After Tax came in at $3.3 billion for Q2 2026 at Novartis Ag, up from $3.2 billion in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $9.1 billion in Q4 2024 to a low of $1.6 billion in Q3 2022.
- Average Profit After Tax over 5 years is $3.9 billion, with a median of $3.2 billion recorded in 2024.
- Year-over-year, Profit After Tax tumbled 66.34% in 2022 and surged 80.66% in 2024.
- Over 5 years, Profit After Tax stood at $5.5 billion in 2022, then jumped by 54.49% to $8.5 billion in 2023, then rose by 7.54% to $9.1 billion in 2024, then retreated by 16.3% to $7.6 billion in 2025, then sank by 57.33% to $3.3 billion in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $3.3 billion in Q2 2026, $3.2 billion in Q1 2026, and $7.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 3.40 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 438.21 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -644.37 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 237.01 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 585.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.16 Bn |
| Dec 31, 2025 | 7.63 Bn |
| Sep 30, 2025 | 3.93 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 9.12 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Dec 31, 2023 | 8.48 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 5.49 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |